Search results
Found 10569 matches for
A trial of a new inhaled antiviral drug for COVID-19 has shown positive results and the drug is now moving into a larger international phase 3 trial of hospitalised patients. MRC HIU's Professor Ling-Pei Ho is one of the main co-authors on the paper.
David Jackson
Group Leaders MRC TIDU
B.A. (Natural Sciences), Ph.D. (Biochemistry) David Jackson - Professor of Human Immunology
Anindita Roy
Group Leaders MRC MHU
MRCPCH FRCPath PhD Anindita Roy - Professor of Paediatric Haematology
Alain Townsend
Group Leaders MRC TIDU
FRS FRCP Alain Townsend - Emeritus Professor of Molecular Immunology
Bethan Psaila
Group Leaders MRC MHU
MA; MBBS; MRCP; FRCPath; PhD Bethan Psaila - Associate Professor of Haematology
Jill Brown
MRC MHU Researchers
BSc (Hons), Postgraduate Certificate in Clinical Cytogenetics Jill Brown - Research Assistant